FAILURE OF THE FIRST BIOLOGIC TREATMENT IN PATIENTS WITH SPONDYLOARTHRITIS: DATA FROM THE MOROCCAN REGISTRY OF BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES (RBSMR)
S. Mikou, Taoufik Harzy, Imane El Mezouar, I. Ghozlani(Régie Autonome Multi Services D'Agadir), H. Hassikou, R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), F. Allali(Délégation Paris 5), I. El Bouchti, Moncef Maiouak, Nessrine Akasbi(Centre Hospitalier Universitaire Hassan II), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), O. Idrissi Ouali(Sidi Mohamed Ben Abdellah University), Redouane Niamane(Hôpital Militaire Avicenne), Saadia Janani(University of Hassan II Casablanca), A. El Maghraoui, Ahmed Bezza(Mohammed V University), L. Ichchou(Hôpital El Ayachi)
Cited by 0
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114